Tags: programmed death 1 inhibitors
VEGF Inhibitors in Renal Cell Carcinoma
Abstract: The arrival of targeted therapies—vascular endothelial growth factor (VEGF) pathway inhibitors and mammalian target of rapamycin (mTOR) inhibitors—and programmed death 1 (PD-1) inhibitors has […]